Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Stock indices serve as market barometers, benchmarks, and investment guides. Learn how they inform decisions and performance tracking.
17,462 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Strategy’s STRC slid to a new all-time low, closing at $89 after a session low of $88.51. Options traders are buildin...
Oracle stock is under pressure amid a tech-wide selloff, but a massive AI backlog could provide durable revenue and u...
Carnival beat on the bottom line and top line, but the stock sank on the day. Analysts point to a price prediction: c...
Tesla's Q2 delivery figures offer a clear window into demand trends and pricing power. This guide breaks down what to...
The AI boom has cooled, but the backbone of AI—data centers and cloud services—remains essential. This guide highligh...
AppLovin shares slipped in June as software peers faced headwinds. This in-depth look explains the catalysts, how the...
As year-to-date markets swing, Disney and PayPal stand out as potential rebound plays. This article weighs dividends,...
Netflix stock has fallen from its peak, heightening focus on engagement metrics. This guide breaks down what to watch...
Jim Cramer tells CNBC’s Mad Money Investing Club to sell Oracle and avoid liquor stocks, outlining a mix of defensive...
What to watch as J.B. Hunt moves into 2026. This analysis breaks down the Q2 dynamics, segment performance, and what ...
AXT Inc. is poised for a pivotal earnings night after a dramatic rally. Look for updates on demand for indium phosphi...